MedPath
TGA Approval

TASIGNA nilotinib 200mg capsules blister pack (133086)

133086

TASIGNA nilotinib 200mg capsules blister pack

Novartis Pharmaceuticals Australia Pty Ltd

January 17, 2008

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/cc1644bd9319e61aae9d18f28f974eb6.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/ee84345992067a35fbcaf1efe4109f99.pdf

Active Ingredients

nilotinib hydrochloride monohydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TASIGNA nilotinib 200mg capsules blister pack (133086) - TGA 批准文号 | MedPath